Vietnam Investment Review on MSN
Imexpharm’s EBITDA margin rises to 22.3 per cent driven by cost management and growth
In September 2025, Imexpharm’s profit before tax surged by 101 per cent, while EBITDA increased by 48 per cent.
Philstar Life on MSN
Johnson & Johnson faces UK lawsuit over talc cancer claim
Thousands of UK claimants have filed legal action against US pharmaceutical and cosmetics giant Johnson & Johnson alleging ...
Kenox Pharmaceuticals Inc. has announced the appointment of Dr. Julianne Berry as Vice President of R&D and Manufacturing. In her new role, Dr. Berry will oversee Kenox's integrated development, ...
Prefilled syringe offers a convenient ready-to-use administration option to healthcare professionals· Marketing authorisation in EU expected in December ...
October 21, 2025 - Nanoform Finland Plc (“Nanoform”), a leading nanoparticle medicine performance-enhancing company, today announced that key findings from two proof-of-concept studies conducted in ...
Techno-Science.net on MSN
⚠️ Inhalers pollute as much as 530,000 cars each year
Inhalers, these essential medical devices for millions of people suffering from asthma or chronic obstructive pulmonary ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback